266 related articles for article (PubMed ID: 9877098)
1. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma.
Tsuboi T; Kondoh H; Hiratsuka J; Mishima Y
Pigment Cell Res; 1998 Oct; 11(5):275-82. PubMed ID: 9877098
[TBL] [Abstract][Full Text] [Related]
2. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.
Hiratsuka J; Kondoh H; Tsuboi T; Yoshino K; Imajo Y; Mishima Y
Melanoma Res; 2000 Jun; 10(3):297-302. PubMed ID: 10890385
[TBL] [Abstract][Full Text] [Related]
3. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
[TBL] [Abstract][Full Text] [Related]
4. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
5. Dual control of melanogenesis and melanoma growth: overview molecular to clinical level and the reverse.
Mishima Y; Kondoh H
Pigment Cell Res; 2000; 13 Suppl 8():10-22. PubMed ID: 11041353
[TBL] [Abstract][Full Text] [Related]
6. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors.
Mishima Y
Pigment Cell Res; 1994 Dec; 7(6):376-87. PubMed ID: 7761345
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.
Hiratsuka J; Yoshino K; Kondoh H; Imajo Y; Mishima Y
Jpn J Cancer Res; 2000 Apr; 91(4):446-50. PubMed ID: 10804294
[TBL] [Abstract][Full Text] [Related]
8. 4-Borono-2-
Ishiwata K
Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
[TBL] [Abstract][Full Text] [Related]
9. Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
Pettersson OA; Olsson P; Lindström P; Sjöberg S; Larsson BS; Carlsson J
Acta Oncol; 1994; 33(6):685-91. PubMed ID: 7946449
[TBL] [Abstract][Full Text] [Related]
10. Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines.
Rossini AE; Dagrosa MA; Portu A; Saint Martin G; Thorp S; Casal M; Navarro A; Juvenal GJ; Pisarev MA
Int J Radiat Biol; 2015 Jan; 91(1):81-9. PubMed ID: 25004948
[TBL] [Abstract][Full Text] [Related]
11. Role of gene expression and protein synthesis of tyrosinase, TRP-1, lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas.
Hara H; Lee MH; Chen H; Luo D; Jimbow K
J Invest Dermatol; 1994 Apr; 102(4):495-500. PubMed ID: 8151127
[TBL] [Abstract][Full Text] [Related]
12. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Ahmad T; Barth RF; Kabalka GW
J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
[TBL] [Abstract][Full Text] [Related]
14. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
Coderre JA; Glass JD; Fairchild RG; Roy U; Cohen S; Fand I
Cancer Res; 1987 Dec; 47(23):6377-83. PubMed ID: 3677082
[TBL] [Abstract][Full Text] [Related]
15. Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.
Morris GM; Micca PL; Nawrocky MM; Weissfloch LE; Coderre JA
Radiat Res; 2002 Dec; 158(6):743-52. PubMed ID: 12452777
[TBL] [Abstract][Full Text] [Related]
16. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.
Miyabe J; Ohgaki R; Saito K; Wei L; Quan L; Jin C; Liu X; Okuda S; Nagamori S; Ohki H; Yoshino K; Inohara H; Kanai Y
J Pharmacol Sci; 2019 Mar; 139(3):215-222. PubMed ID: 30833090
[TBL] [Abstract][Full Text] [Related]
17. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma.
Fukuda H; Honda C; Wadabayashi N; Kobayashi T; Yoshino K; Hiratsuka J; Takahashi J; Akaizawa T; Abe Y; Ichihashi M; Mishima Y
Melanoma Res; 1999 Feb; 9(1):75-83. PubMed ID: 10338337
[TBL] [Abstract][Full Text] [Related]
19. Analyses of mixed melanogenesis in tyrosinase cDNA-transfected human amelanotic melanoma cells.
Ando O; Mishima Y; Hanada S; Suemoto Y; Atobe J; Kurimoto M
J Invest Dermatol; 1993 Dec; 101(6):864-70. PubMed ID: 8245515
[TBL] [Abstract][Full Text] [Related]
20. Capillary electrophoresis-electrospray mass spectrometry and HR-ICP-MS for the detection and quantification of 10B-boronophenylalanine (10B-BPA) used in boron neutron capture therapy.
Pitois A; de las Heras LA; Zampolli A; Menichetti L; Carlos R; Lazzerini G; Cionini L; Salvatori PA; Betti M
Anal Bioanal Chem; 2006 Feb; 384(3):751-60. PubMed ID: 16372182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
